Download presentation
Presentation is loading. Please wait.
Published bySherman Palmer Modified over 9 years ago
1
SLE and Cardiovascular Disease Mario J. Garcia, MD, FACC, FACP Chief, Division of Cardiology Professor of Medicine and Radiology
2
Lupus and the Heart SLE is a chronic, inflammatory disease with circulating Autoantibodies (“anti-self”); activated T cells (tissue autoimmunity); immune complexes (Antigen- Antibody) and inflammatory Cytokines (cell messenger proteins) Lupus Therapy over the last 4 decades has converted a rapidly fatal disease into a chronic condition
3
Cardiac Involvement in Lupus All “layers” of the heart can be involved: 1)Pericardium 2)Myocardium 3)Valves 4)Electrical System 5)Coronary Vessels
4
Pericarditis Inflammation of the Pericardium occurs in 11-54% of Lupus patients Often occurs at Onset or with Relapses Pericarditis is the most characteristic feature and is one of the ACR/ARA Classification Criteria for Lupus “Sharp” chest pain, fever Treated with NSAIDs or Steroids
5
Myocarditis Inflammation (“Myocarditis”) occurs in 7-10% of cases (and is treated with Steroids) Can lead to Heart Failure
6
Valvular Disease Inflammatory lesions usually on Mitral or Aortic Valves (both active and healed) “Verrucous” or Libman-Sacks lesions characteristic but not usual Valve Leaking or Stroke
7
Heart Block Conduction “Block” rare in adults Seen in 2% of children born to mothers with Anti-Ro/SSA positive Lupus
8
Coronary Disease Coronary Arteries carry blood supply the working muscle of the heart Coronary Artery Disease in 6-10%; Lupus patients have a 4-8 fold increased risk Smaller vessel inflammation (vasculitis)-usually in younger patients with active SLE Larger vessel inflammation (atherosclerosis)-usually in older patients with long-standing SLE
10
Calcification Lipid Cor Inflammation Thrombus
11
Coronary Calcium Score Moderate Calcification NormalSevere Calcification
12
Roman; NEJM; 2003
13
Coronary CTA
14
Stress Testing
15
Catheterization
16
Coronary Bypass and Stents
17
Carotid Ultrasound
18
Lumen IMT LumenStenosis
19
Asanuma; NEJM; Dec 18, 2003
21
An Ounce of Prevention…
22
Diet Modification: Healthy Choices Fruits and Vegetables Whole Grain and High Fiber Oily (cold water) fish 2 x / week Alcoholic drink not > 1/day Sodium (Na+) < 2.3 gram/day Saturated Fat < 10% of total calories Limit Trans-Fat: Baked Goods and Fried Foods
23
Cardiac (Exercise) Rehab Prevents 23 deaths per 1000 patients Safety: Mortality 1 / 784,000 pt-hours Cost: $1200 / QOL-year (comparable to Left main surgery!) By comparison, Dialysis costs $40,000 / QOL-yr Usually 3 x /week for 12-16 weeks
24
Smoking Cessation Smokers have 3 x the risk of MI of non-smokers Cessation prevents 70 deaths per 1000 patients x 1 year
25
Medical Treatment A—Aspirin and ACE Inhibitors B—Beta Blockers and Blood Pressure C—Cholesterol / Cigarettes / Clopidogrel D—Diet (for Weight and Diabetes) E—Exercise and Education Conti, CR Clin. Cardiology 2007
26
LDL Cholesterol Goals < 10%<160 mg/dl0-1 Risk Factors 10-20%< 130 mg/dl2 or more Risk Factors > 20%< 100 mg/dlCHD or Equivalent 10 year event rateLDL GoalRisk Factor
27
Other Cholesterol Goals “Lupus” Lipid profile often has low HDL (“good” cholesterol), high Triglycerides and high Lp(a) (a lipoprotein that ties into the clotting cascade) Lp(a) may be modifiable with exercise and Niacin
28
Treating Cholesterol High Total and LDL Cholest Statins (zocor, lipitor, crestor) High Trig and Low HDL Cholest Fibrates (lopid, tricor) High LDL and Trig and low HDL Cholest Niacin (niaspan) High Triglycerides prescript. Fish oil (Omega 3 FAs) (lovaza)
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.